RxDoctor Payments Data

Wyatt Nash-Keller

Optometrist · Brookings, SDNPI 1124371992

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $683 of the $1,113 with a category attached, or 61.4%. Johnson & Johnson Vision Care, Inc. accounts for 60.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $509 and has fallen 65.9% since, to $173 in 2025.

$1,113in general payments, 2019–2025

Across 37 payments — averaging $30.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$674
  • Bausch & Lomb Americas Inc.$154
  • Coopervision Inc.$101
  • Tarsus Pharmaceuticals, Inc.$54
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$43
  • Alcon$33
  • plus $52 from 3 others
$109in research payments, 2019–2025

Across 1 payment — averaging $108.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$109

What the payments were for

  • Consulting fees$41037%
  • Food & beverage$68361%
  • Gifts$192%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,113 in reported general payments places this provider in the 70th percentile of 206 optometrist providers in South Dakota.

See all optometrist providers in South Dakota

Medicare billing

Part B allowed, 2024
$13,606
Medicare patients
84
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost16$6,227
Prednisolone Acetate18$670
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha24$282
Latanoprost51$239
Timolol Maleate20$59

Paid to pharmacies, not to this prescriber.

Other optometrist in Brookings

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →